CRP and Hyperglycemia: SeNP and/or BV treatments improved the deleterious effects induced with STZ administration by improving the serum insulin concentrations, which resulted in decreasing the hyperglycemia, decreasing the serum BUN, creatinine and CRP while increasing the serum albumin concentrations.